期刊文献+

外用青黛治疗桥本甲状腺炎疗效及其对甲状腺自身免疫性抗体的影响 被引量:31

Efficacy of Indigo Naturalis Topical Treatment of Hashimoto's Thyroiditis and Its Effects on Serum TGAb and TPOAb
下载PDF
导出
摘要 目的:观察外用青黛对桥本甲状腺炎(HT)血清中甲状腺球蛋白抗体(TGAb)、甲状腺过氧化物酶抗体(TPOAb)的影响。方法将65例HT患者随机分为治疗组33例和对照组32例。2组甲状腺功能亢进、甲状腺功能减退者分别予甲巯咪唑片10 mg/d、左旋甲状腺素片25~50μg/d控制甲状腺功能,稳定2周后,治疗组在此基础上于颈前甲状腺投射区域局部外敷青黛治疗,疗程6个月。结果中医临床证候2组均有改善,组间比较差异有统计学意义(P<0.05,P<0.01)。治疗组中医证候疗效为81.82%(27/33),对照组为65.63%(21/32),2组比较差异有统计学意义(P<0.01)。治疗组临床疗效总有效率为84.85%(28/33),对照组为71.88%(23/32),2组比较差异有统计学意义(P<0.05)。治疗组治疗后血清 TGAb、TPOAb 水平较治疗前下降(P<0.05),2组比较差异有统计学意义(P<0.01)。结论外用青黛治疗HT可提高疗效,并能有效降低甲状腺自身免疫性抗体指标。 Objective To observe the efficacy of topical indigo naturalis on the serum thyroglobulin antibody (TGAb) and thyroid peroxidase antibody (TPOAb) in Hashimoto's thyroiditis (HT). Methods Sixty-five cases of HT were randomly divided into the treatment group (33 cases) and the control group (32 cases). Hyperthyroidism patients and hypothyroidism patients in the two groups were treated with methimazole 10 mg/d and levothyrocine 25-50 μg/d to control their thyroid function. Based on the basic treatment, patients in the treatment group were treated with topical indigo naturalis local external application, which lasted for 6 months. Results TCM clinical symptoms were improved in both two groups, with statistical significance between the two groups (P〈0.05, P〈0.01). The efficacy of TCM clinical symptoms was 81.82% (27/33) in the treatment group and 65.63% (21/32) in the control group, with statistical significance (P〈0.01). The total effective rate of the treatment group was 84.85% (28/33) and the control group was 71.88%(23/32), with statistical significance between the two groups (P〈0.05). Compared with that before treatment, the levels of TGAb and TPOAb were lower in both groups (P〈0.05), and with statistical significance between the two groups (P〈0.01). Conclusion Indigo naturalis can improve efficacy of treatment for HT, and effectively reduce autoimmune antibodies indicators of thyroid.
出处 《中国中医药信息杂志》 CAS CSCD 2014年第11期24-27,共4页 Chinese Journal of Information on Traditional Chinese Medicine
关键词 青黛 桥本甲状腺炎 甲状腺球蛋白抗体 甲状腺过氧化物酶抗体 中医药疗法 indigo naturalis Hashimoto's thyroiditis thyroglobulin antibody thyroidpcroxidase antibody traditional Chinese medicine therapy
  • 相关文献

参考文献17

  • 1Thomas Heiberg Brix and Laszlo Hegedus. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease[J]. Clinical Endocrinology, 2012,76: 457-464.
  • 2RhoMtt, KimDW, Hong HP, et al. Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on bistopathologic results[J]. Endocrine, 2012,42(3): 647-652.
  • 3中国甲状腺疾病诊治指南——甲状腺炎:亚急性甲状腺炎[J].中华内科杂志,2008,47(9):784-785. 被引量:562
  • 4李东,武彦舒,王灿,孙琴.青黛镇痛、抗炎药效学研究[J].中国实验方剂学杂志,2011,17(13):137-140. 被引量:48
  • 5张敏,张毅.益气化痰消瘿法对桥本甲状腺炎患者血清甲状腺球蛋白抗体、甲状腺过氧化物酶抗体的影响[J].中医杂志,2007,48(5):414-415. 被引量:40
  • 6ZeitlinAA, HewardJM, Newby PR, et al. Analysis of HLA class Ⅱ genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease[J]. Genes Immun, 2008, 9(4): 358-363.
  • 7Flynn JC, Meroueh C, Shower DP, et al. Depletion of CD4+CD25* regulatory T cells exacerbates sodium'iodide-induced experimental autoimmunethyroiditis in human leucocyte antigen DR3 (DRBI*0301) transgenic class II-knock-out non-obese diabetic mice[J]. Clin Exp Immunol, 2007,147(3): 547-554.
  • 8Swist E, Chen Q, Qiao C, et al. Excess dietary iodine differentially affects thyroid gene expression in diabetes, thyroiditis-prone versus-resistant BioBreeding (BB) rats[J]. Mol Nutr Food Res, 2011,55(12): 1875-1886.
  • 9Yamazaki K, Tanigawa K, Suzuki K, et al. Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin[J]. Thyroid, 2010,20(1): 67-76.
  • 10Liu Z, Wang H, Xiao W, et al. Thyrocyte interleukin-18 expression is up-regulated by interferon-y and may contribute to thyroid destruction in Hashimoto's thyroiditis[J]. Int J Exp Pathol, 2010,91(5): 420-425.

二级参考文献19

  • 1张群,邹爱东,阚玉梅.青黛的临床应用与不良反应[J].实用药物与临床,2004,7(3):45-47. 被引量:20
  • 2Iitaka M, Momotani N, Ishii J, et al. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab, 1996,81:466-469.
  • 3Davies TF,Larsen PR. Thyrotixicosis//Larsen PR, Kronenberg HM, Melmed S. Wlilliams textbook of endocrinology. 10th ed. Philadelphia : Saunders, 2002 : 423-456.
  • 4Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med, 2003,349:2646-2655.
  • 5Fatourechi V, Aniszewski JP, Fatourechi GZ, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort : Olmsted County, Minnesota, study. J Clin Endocrinol Metab, 2003, 88:2100-2105.
  • 6Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am, 1998,27 : 169-185.
  • 7滕卫平.甲状腺炎//叶任高.内科学.6版.北京:人民卫生出版社.2005:739-742.
  • 8高燕明,高妍.甲状腺炎//刘新民.实用内分泌学.3版.北京:人民军医出版社,2003:258-290.
  • 9白耀.甲状腺炎//白耀.甲状腺病学-基础与临床.北京:科学技术文献出版社,2004:305-323.
  • 10中国药典,一部[S].2010:263.

共引文献645

同被引文献437

引证文献31

二级引证文献232

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部